Karen Bernstein

Insider Reports History

Location
Fort Washington, PA
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karen Bernstein:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ovid Therapeutics Inc. Director Stock Option (right to buy) 45,000 20 Feb 2025 Direct
Codiak BioSciences, Inc. Director Common Stock 8,750 16 Feb 2023 Indirect
Codiak BioSciences, Inc. Director Stock Option (Right to Buy) 7,500 17 Jun 2022 Indirect
Codiak BioSciences, Inc. Director Restricted Stock Units 0 16 Feb 2023 Indirect

Insider Reports Filed by Karen Bernstein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OVID Ovid Therapeutics Inc. 20 Feb 2025 1 $0 4 Director 18 Jun 2025, 16:45
OVID Ovid Therapeutics Inc. 12 Dec 2024 1 $0 4 Director 16 Dec 2024, 16:15
OVID Ovid Therapeutics Inc. 22 Feb 2024 1 $0 4 Director 26 Feb 2024, 17:53
OVID Ovid Therapeutics Inc. 23 Feb 2023 1 $0 4 Director 27 Feb 2023, 15:44
/report/000089924323005693-bernstein-karen-2023-02-16 Codiak BioSciences, Inc. 16 Feb 2023 2 $0 4 Director 21 Feb 2023, 15:31
/report/000089924322023403-bernstein-karen-2022-06-17 Codiak BioSciences, Inc. 17 Jun 2022 2 $0 4 Director 21 Jun 2022, 16:48
OVID Ovid Therapeutics Inc. 08 Apr 2022 1 $0 4 Director 12 Apr 2022, 16:44
/report/000089924322007016-bernstein-karen-2022-02-16 Codiak BioSciences, Inc. 16 Feb 2022 1 $0 4 Director 18 Feb 2022, 15:06
OVID Ovid Therapeutics Inc. 03 Feb 2022 1 $0 4 Director 04 Feb 2022, 19:47
/report/000089924321025399-bernstein-karen-2021-06-18 Codiak BioSciences, Inc. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 19:17
OVID Ovid Therapeutics Inc. 11 Jun 2021 1 $0 4 Director 11 Jun 2021, 20:15
OVID Ovid Therapeutics Inc. 17 May 2021 1 $0 4 Director 18 May 2021, 20:51